外科理论与实践 ›› 2019, Vol. 24 ›› Issue (01): 65-69.doi: 10.16139/j.1007-9610.2019.01.014

• 论著 • 上一篇    下一篇

单孔加一孔腹腔镜手术在直肠癌治疗中应用的初步研究

李军, 李佑, 施毅卿, 刘坤, 蒋奕玫, 宋子甲, 赵任   

  1. 上海交通大学医学院附属瑞金医院北院外科,上海 201801
  • 收稿日期:2018-07-20 出版日期:2019-01-25 发布日期:2019-02-25
  • 通讯作者: 李佑,E-mail: lyb1013@rjhn.com.cn

Single-incision plus one laparoscopic surgery in treatment of rectal cancer: a preliminary study

LI Jun, LI You, SHI Yiqing, LIU Kun, JIANG Yimei, SONG Zijia, ZHAO Ren   

  1. Department of Surgery, Ruijin Hospital North, Shanghai Jiao Tong University School of Medicine, Shanghai 201801, China
  • Received:2018-07-20 Online:2019-01-25 Published:2019-02-25

摘要: 目的: 研究单孔加一孔腹腔镜手术在直肠癌根治术中的可行性、安全性、肿瘤根治程度、近期疗效以及操作优势。方法: 回顾性分析2013年9月至2018年1月间,在我科接受单孔加一孔腹腔镜直肠癌根治术20例病人的临床资料。另从采用单孔腹腔镜手术的直肠癌病人(n=62)中按1∶1的比例进行倾向性评分匹配,选出20例作为对照组。倾向性评分匹配因素包括年龄、性别、体质量指数(body mass index, BMI)、美国麻醉协会分级(≤2/>2)和 TNM(0~Ⅰ/Ⅱ/Ⅲ)分期。分析两组的临床资料以及手术结果。结果: 两组在手术时间、术中出血量、肿瘤大小、淋巴结清扫数、切口长度以及术后住院时间上,均无统计学差异。肿瘤距肛缘的距离上在两组间有统计学差异(P<0.05)。单孔加一孔组的中位随访时间为24.5个月,对照组为26.5个月。两组均无肿瘤复发。结论: 单孔加一孔腹腔镜直肠癌根治术可行和安全,可用于治疗距肛缘更近的直肠癌。

关键词: 单孔加一孔腹腔镜, 直肠癌, 单孔腹腔镜手术

Abstract: Objective To assess feasibility and safety of single-incision plus one laparoscopic surgery (SILS+1) in radical treatment of rectal cancer combined with analysis of short-term clinical and oncological outcomes. Methods Clinical data were studied retrospectively with 20 patients who underwent radical rectal cancer resection through SILS+1 from September 2013 to January 2018 in our department. A propensity score matching approach was used on pooled the data of 62 cases with single-incision laparoscopic surgery of rectal cancer at a radio of 1∶1 as control group of 20 cases after matching the demographic information of the patients and body mass index, American Society of Anesthesiologists score (≤2/>2) and TNM (0-Ⅰ/Ⅱ/Ⅲ) stage. Clinical data and operative results were analyzed between SILS+1 group and control group. Results No significant differences were observed in operative time, blood loss, tumor size, retrieved lymph node, length of incision, postoperative hospital stay between SILS+1 group and control group. However, SILS+1 group showed significantly shorter distance of rectal cancer from the anal verge (P<0.05). The median follow-up period was 24.5 months in SILS+1 group and 26.5 months in control group. There was no recurrent case in both groups. Conclusions SILS+1 for rectal cancer is feasible and safe, and can be used to treat rectal cancer more near from the anal verge.

Key words: Single-incision plus one laparoscopic surgery, Rectal cancer, Single-incision laparoscopic surgery

中图分类号: